A vendor demo is designed to be persuasive, not representative. The workflow on stage has been rehearsed, the sample patient record has no messy real-world history, and the sales engineer driving the screen has years of practice making a dozen clicks look like two. Health systems that select an EHR based primarily on how good the demo looked are selecting for presentation skill, not for how the system will perform on a Tuesday afternoon with a full patient panel, a slow network segment, and a nurse who has never used it before.

EHR vendor selection is one of the highest-stakes technology decisions a health system makes — contracts run seven to ten years, switching costs are enormous, and a poor fit shows up as clinician attrition and safety-relevant workarounds long after the ink is dry. Getting it right means replacing demo-driven intuition with a structured process: a real request for proposal, third-party usability and satisfaction data, clinician-scripted use cases run on the actual candidate system, and a total-cost-of-ownership model that goes well past the license fee.

Why does the demo mislead buyers so consistently?

Vendor demonstrations are built around “happy path” scenarios — a straightforward visit type, a cooperative patient record, and a presenter who has memorized the fastest route through the interface. They rarely show what happens when a patient has fourteen active problems, three home medications need reconciling against a stale outside record, and the clinician is trying to do all of it inside a fifteen-minute visit slot. The demo also almost never shows the system under real load: multiple concurrent users, a report queue backed up, or the specific specialty workflow (oncology chemo ordering, OB triage, ED throughput) that will define whether frontline staff tolerate the system or fight it every day.

The fix is not to distrust vendors — it’s to change who controls the script. Selection committees that let the vendor choose every scenario see only what the vendor wants shown. Committees that hand the vendor a packet of the organization’s own representative, messy use cases — pulled from real (de-identified) encounters — see something much closer to what go-live will actually look like.

What does a real RFP process add that a demo tour doesn’t?

A formal request for proposal forces vendors to commit specifics in writing rather than verbally reassure a room. A well-built health-IT RFP typically requires vendors to respond in detail to:

  • Functional requirements organized by clinical and operational domain (ordering, documentation, medication management, results review, patient engagement, revenue cycle integration), scored against the organization’s actual priority weighting rather than a generic checklist
  • Interoperability capabilities, including certified FHIR API support under the ONC Health IT Certification Program, existing interface engine compatibility, and named health information exchange participation
  • Implementation methodology and staffing, including named go-live support ratios, training hours per role, and post-go-live optimization support duration
  • Security and compliance posture, including SOC 2 reporting, HIPAA Security Rule risk assessment history, and specifics on encryption at rest and in transit
  • Reference sites matched by organization size, specialty mix, and — critically — by how long the reference site has been live, since a six-month-old reference and a five-year reference tell very different stories about long-term satisfaction

RFP responses become the contractual baseline. A vendor’s written commitment on interface count, data migration scope, or support response time is enforceable in a way that a sales conversation is not.

Where does KLAS and other third-party data fit into the decision?

Independent research firms that survey healthcare organizations about their live EHR experience — most prominently KLAS Research — provide something a vendor’s own reference list cannot: aggregated satisfaction data across hundreds of live sites, broken out by category (overall satisfaction, loyalty, avoidability of workarounds) and often by organization size and specialty. This data should inform the shortlist before the RFP goes out, not just confirm a decision already made.

Third-party data is not a substitute for direct evaluation — vendor rankings shift, and a strong aggregate score does not guarantee fit for a specific organization’s specialty mix or size tier. But a vendor whose live customers consistently report low loyalty or high workaround rates in independent surveys is a meaningfully different risk proposition than one with strong client-reported outcomes, and that signal is easy to ignore when a demo went well.

Why do clinician-led, scripted use cases matter more than a guided tour?

The single highest-value step in a rigorous selection process is putting the organization’s own clinicians — not the vendor’s presenter — at the keyboard, running scripted use cases built from the organization’s real workflow, on the actual candidate system in a sandbox environment. This surfaces problems a guided demo is specifically designed to avoid:

  • Click count and navigation depth for the organization’s actual most common order sets and documentation templates, not the vendor’s idealized workflow
  • Specialty-specific gaps — an oncology infusion order, a behavioral health assessment, an OB triage pathway — that a generic ambulatory demo never touches
  • Alert and decision-support behavior under the organization’s actual formulary and allergy-checking configuration, since default vendor settings are frequently far noisier or quieter than what the organization intends to run in production
  • Downtime and recovery workflow — what a clinician actually sees and does when the system is degraded, which almost never appears in a sales demo

Scripted use cases take longer to organize than a vendor demo tour, and they require pulling frontline clinicians — the people who will use the system daily — into the selection process directly rather than leaving the decision to IT leadership and finance alone. That investment is what separates a selection process that predicts real satisfaction from one that predicts nothing beyond how polished the sales team was.

What does total cost of ownership actually include?

License and subscription fees are the most visible cost and often the smallest piece of the real number. A defensible total-cost-of-ownership model spans the full contract term and includes:

  • Implementation services — vendor professional services, third-party implementation partners if used, and the internal FTE cost of the project team for the duration of the build
  • Interface development and maintenance — per-interface fees for every lab, radiology, pharmacy, and specialty system connection, plus ongoing maintenance as those interfaces change over the contract
  • Data migration — extracting, mapping, and validating data from the legacy system, which is frequently underestimated and is a direct link to the legacy-system decommissioning problem organizations eventually face when the old platform is finally retired
  • Training and productivity loss during transition — both formal training hours and the temporary throughput drop that accompanies any major EHR transition
  • Ongoing optimization staffing — the analyst and informatics FTEs needed post-go-live, since a system that is never tuned after initial build tends to accumulate the workaround and alert-fatigue problems that drive dissatisfaction
  • Annual maintenance and upgrade fees, including whether major version upgrades are included or billed separately

Organizations that model only the license fee routinely find the total contract cost is two to three times the number that appeared in the initial vendor quote. Building the full model before signing — not after — is what keeps the eventual finance conversation from becoming an adversarial one.

Frequently Asked Questions

Why is a vendor demo a poor basis for an EHR selection decision?

A demo is scripted by the vendor around “happy path” scenarios using an idealized sample record. It rarely reflects the organization’s actual specialty mix, patient complexity, or system performance under real load, so it predicts presentation quality more than day-to-day clinician experience.

What is the most valuable step in a rigorous selection process?

Letting the organization’s own clinicians run scripted use cases — built from real, de-identified encounters — directly on the candidate system in a sandbox, rather than watching a vendor-led guided tour. This surfaces specialty gaps and click-count problems a demo is designed to hide.

How reliable is KLAS Research data for EHR selection?

It provides valuable aggregated, independent satisfaction data across live sites, which a vendor’s own reference list cannot. It should inform the shortlist, not replace direct evaluation — rankings shift and aggregate scores don’t guarantee fit for a specific organization’s size or specialty mix.

What does total cost of ownership include beyond the license fee?

Implementation services, per-interface development and maintenance fees, data migration, training and transition productivity loss, ongoing optimization staffing, and annual maintenance/upgrade fees — typically two to three times the license quote alone.

How long do EHR vendor contracts typically run?

Most enterprise EHR contracts run seven to ten years, which is part of why a demo-driven decision carries outsized long-term risk — the organization is committing to daily clinician experience and total cost for the better part of a decade.

This article is intended for general informational purposes for health IT professionals and does not constitute legal, procurement, or medical advice. Organizations should engage qualified procurement, legal, and clinical informatics staff for vendor selection decisions specific to their environment.